CURIS, INC. Deferred Tax Liabilities, Gross
CURIS, INC. (CRIS) had Deferred Tax Liabilities, Gross of $511.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-03-24
- 2025-12-31: Deferred Tax Liabilities, Gross $511.00K.
- 2024-12-31: Deferred Tax Liabilities, Gross $863.00K.
- 2023-12-31: Deferred Tax Liabilities, Gross $836.00K.
- 2022-12-31: Deferred Tax Liabilities, Gross $1.20M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $511.00K 10-K · filed 2026-03-24 |
| 2024-12-31 | $863.00K 10-K · filed 2026-03-24 |
| 2023-12-31 | $836.00K 10-K · filed 2025-03-31 |
| 2022-12-31 | $1.20M 10-K · filed 2024-02-08 |
| 2021-12-31 | $1.56M 10-K · filed 2023-03-13 |
| 2020-12-31 | $1.79M 10-K · filed 2022-02-24 |
| 2019-12-31 | $41.00K 10-K · filed 2021-03-16 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |